Саркопенія при цукровому діабеті 2-го типу (огляд і власні спостереження)

O.A. Goncharova

doi:10.22141/2224-0721.13.2.2017.100611

PDF (Русский)

DOI: https://doi.org/10.22141/2224-0721.13.2.2017.100611

Keywords:

sarcopenia, carbohydrate metabolism, physical activity, review

O.A. Goncharova

Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine

Abstract

Background. A review of the literature on sarcopenia syndrome presents its definition, classifications and etiological factors. The main attention is paid to the correlation between sarcopenia and carbohydrate metabolism, in particular, between glycogen content and insulin sensitivity. The publications dealing with the mechanisms of influence of physical activity (short-term and long-term) on carbohydrate metabolism are analyzed. It is emphasized that today there is an evidence base on the role of skeletal muscles in maintaining glucose homeostasis, which justifies the importance of physical activity for the prevention of type 2 diabetes mellitus (DM) and monitoring such patients. Our observations were carried out to compare the frequency of the increase in the percentage of fat tissue (FT) and the reduction in muscle tissue in patients with different body mass index (BMI) and the effects of type 2 DM on these indicators. Materials and methods. A bioimpedance study was performed in 114 patients with type 2 DM aged 52.3 ± 1.7 years and 110 persons of the same age without type 2 DM (control group). Results. In all those surveyed with overweight and obesity, the age norms of percentage of FT were increased, regardless of the presence or absence of type 2 DM. At normal body weight in the control group in almost half of the examinees (52.0 %), there was an increase in the specific weight of the FT, and in the presence of type 2 DM, this index was significantly higher (94.1 %). This suggests that exceeding the age norms for the percentage of FT in persons with normal body weight can be regarded as a risk factor for type 2 DM. Conclusions. The incidence of a decrease in the specific weight of FT in the control group was 8.0 % in normal body weight, 20.0 % — in overweight and 80.0 % — in obesity that indicates the significance of the problem of sarcopenia, primarily in persons with obesity. Against the background of type 2 DM, these rates were significantly higher with normal body weight (41.2 %, p < 0.02), 2 times higher — with overweight, but lower (unreliably) — with obesity (61.1 %). The problem of sarcopenia in DM type 2 is relevant for patients with various BMI.

How to Cite

Goncharova, O. “Sarcopenia in Type 2 diabetes Mellitus (review and Own Observations)”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 2, May 2017, pp. 186-94, doi:10.22141/2224-0721.13.2.2017.100611.

Issue

Vol. 13 No. 2 (2017)

Section

Literature Review

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.

References

World Health Organization. Report of the WHO consultation on obesity. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization, 1998. Available at: www.who.int/iris/handle/10665/63854. Accessed 1998.

Bahadori B, Uitz E, Tonninger-Bahadori K, Pestemer-Lach I. et al. Body composition: the fat-free mass index (FFMI) and the body fat mass index (BFMI) distribution among the adult Austrian population — results of a cross-sectional pilot study. International Journal of Body Composition Research. 2006;4(3):123-8.

Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71-82. doi:10.1001/jama.2012.113905.

Carnethon MR, et al. Association of Weight Status with Mortality in Adults with Incident Diabetes. JAMA. 2012;308(6):619-20. doi: 10.1001%2Fjama.2012.9282.

Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009 Jul;250(1):166-72. PMID: 19561456. doi: 10.1097/SLA.0b013e3181ad8935.

Trushkina IV, Filippov GP, Leontieva IV. Structure of body in patients with overweight. Sibirskiy meditsinskiy zhurnal. 2010;3(1):38-44. (in Russian).

Romero-Corral A, Somers VK, Sierra-Johnson J. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010 Mar;6:737-46. PMID: 19933515. doi: 10.1093/eurheartj/ehp487.

Goncharova OA, Partzhaladze VI, Iliyna IM. Metabolic obesity in normal body weight. Unsolved issues of diagnostics. Endokrynologiya. 2013;4:50-4. (in Russian).

Karachentsev YI, Goncharova OA, Partzhaladze VI, Iliyna IM. Diagnostics of metabolic obesity in patients with type 2 diabetes mellitus with normal body weight. Anthropometric methods. Kyiv, 2014. 4 p. (in Ukrainian).

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. PMID: 20392703. doi: 10.1093/ageing/afq034.

Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):1-7. PMID: 19915458. doi: 10.1097/MCO.0b013e328333c1c1.

Cawthon PM, Marshall LM, Michael Y, et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007 Aug;55:1216-23. PMID: 17661960. doi: 10.1111/j.1532-5415.2007.01259.x.

Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769-74. PMID: 17493199. doi: 10.1111/j.1532-5415.2007.01140.x.

Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: The health, aging and body composition study. J Gerontol Biol Sci Med Sci. 2006 Oct;61(10):1059-64. PMID: 17077199.

Pedersen BK, Febbraio MA. Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6. Physiol Rev. 2008 Oct:88(4):1379-1406. PMID: 18923185. doi: 10.1152/physrev.90100.2007.

Vasina AY, Didur MD, Yygi AA. et al. Muscular tissue as endocrine regulator and the problem of physical inactivity. Vestnik Sankt-Peterburgskogo universiteta. Seruya 11. Meditsina. 2014;2:5-15. (in Russian).

Chernozub AA. Safe and critical levels of physical activities for the trained and untrained persons in the conditions of muscular activity of power orientation. Fiziologichnyi zhurnal. 2016;62(2):110-6. (in Ukrainian).

Sakharov DA, Tevis M, Tonevitskiy AH. Analysis of human basic isoform of growth hormone before and after intensive physical activities. Bulleten’ eksperimental’njy biologii i meditsiny. 2008;146(10):446-50. (in Russian).

Lima-Cabello E, Cuevas MJ, Garatachea N. et al. Eccentric exercise induces nitric oxide synthase expression through nuclear factor-kB modulation in rat skeletal muscle. J Appl Physiol. 2010;108:578-83. PMID: 20044475. doi: 10.1152/japplphysiol.00816.2009.

Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocrine Regulation. 2009;43(4):157-68. PMID: 19908934.

Noskov SM, Margazin VA, Noskova AS. Paradox of obesity: muscular hypothesis and tactics of physical rehabilitation. Lechebnaya fizkul’tura i sportivnaya meditsina. 2010;6(78):53-60. (in Russian).

Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG. Quantification of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med. 1990 Jan;322(4):223-8. PMID: 2403659. doi: 10.1056/NEJM199001253220403.

Jensen J, Rustad P, Kolnes AJ, Lai YC. The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise. Front Physiol. 2011;2(112):56-67. doi: 10.3389%2Ffphys.2011.00112.

Volek JS, Freidenreich DJ, Saenz C, Kunces LJ, Creighton BC, Bartley JM, Davitt PM, Munoz CX, Anderson JM, Maresh CM, Lee EC, Schuenke MD, Aerni G, Kraemer WJ, Phinney SD. Metabolic characteristics of keto-adapted ultra-endurance runners. Metabolism. 2016;65(3):100-10. PMID: 26892521. doi: 10.1016/j.metabol.2015.10.028.

Matiunina YV, Kurashvili VA. A role of endogenous glycogen in the increase of endurance of organism. Vestnik sportivnykh innovatsiy. 2016;52:1-30. (in Russian).

Nakonechnaya OA, Gorbach TV, Martynova SN, Yarmysh NV, Tkachenko AS. Diagnostika glikogenozov. Metodicheskie ukazanija dlja samostojatel'noj podgotovki studentov medicinskih i stomatologicheskogo fakul'tetov po biologicheskoj himii [Glycogenosis diagnosis. Methodical guidance for independent preparation of students medical and stomatological faculties on biological chemistry]. Kharkiv, 2016. 35 p. (in Russian).

Vendelbo MH, Clasen BF, Treebak JT, Moller L, Krusenstjerna-Hafstrom T, et al. Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle. Am J Physiol Endocrinol Metab. 2012 Jan 15;302(2):190-200. PMID: 22028408. doi: 10.1152/ajpendo.00207.2011.

Vendelbo MH, Møller AB, Christensen B, Nellemann B, Clasen BFF, Nair KS, et al. Fasting Increases Human Skeletal Muscle Net Phenylalanine Release and This Is Associated with Decreased mTOR Signaling. PLoS ONE. 2014 July 14;9(7):1020-31. doi: 10.1371/journal.pone.0102031.

Prebil M, Jensen J, Zorec R, Kreft M. Astrocytes and energy metabolism. Arch Physiol Biochem. 2011 May;117:64-9. PMID: 21214428. doi: 10.3109/13813455.2010.539616.

Ovsiannikov VG. Obshhaja patologija: patologicheskaja fiziologija: uchebnik [General pathology: physiopathology]. Rostov, 2015. 247 p. (in Russian).

Egan B, Zierath JR. Exercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation. Cell Metabolism. 2013;17(2):162-84. PMID: 23395166. doi: 10.1016/j.cmet.2012.12.012.

Rui L. Energy metabolism in the liver. Compr Physiol. 2014 Jan;4(1):177-197. PMID: 24692138. doi: 10.1002/cphy.c130024.

Matsui T, Ishikawa T, Ito H, Okamoto M, Inoue K, Lee MC, Fujikawa T, Ichitani Y, Kawanaka K, Soya H. Brain glycogen supercompensation following exhaustive exercise. Physiol. 2012 Feb 1;590(3):607-16.

Jensen J. The role of skeletal muscle glycolysis in whole body metabolic regulation and type 2 diabetes. In Glycolysis: Regulation, Processes and Diseases. Lithaw H., editor. New York: Nova Science Publishers, Inc. 2009:5-83.

Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006 Feb;7(2):85-96. PMID: 16493415. doi: org/10.1038/nrm1837.

Lauritzen HP. Insulin- and contraction-induced glucose transporter 4 traffic in muscle: insights from a novel imaging approach. Exerc Sport Sci Rev. 2013;41(2):77-86. PMID: 23072821. doi: 10.1097/JES.0b013e318275574c.

Shepherd PR. Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol Scand. 2005;183:3-12. PMID: 15654916. doi: 10.1111/j.1365-201X.2004.01382.x.

Larance M, Ramm G, James DE. The GLUT4 code. Mol Endocrinol. 2008 Feb;22(2):226-33. PMID: 17717074. doi: 10.1210/me.2007-0282.

Schultze SM, Jensen J, Hemmings BA, Tschopp O, Niessen M. Promiscuous affairs of PKB/AKT isoforms in metabolism. Arch Physiol Biochem. 2011;117:70-7. PMID: 21214427. doi: 10.3109/13813455.2010.539236.

Li MV, Chen W, Harmancey RN, et al. Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP). Biochem Biophys Res Commun. 2010 May 7;395(3):395-400. PMID: 20382127. doi: 10.1016/j.bbrc.2010.04.028.

Bouskila M, Pajvani UB, Scherer PE. Adiponectin: a relevant player in PPAR--agonist-mediated improvements in hepatic insulin sensitivity? Int J Obes.Relat. Metabol Disord. 2005 Mar;29(1):17-23. PMID: 15711577. doi: 10.1038/sj.ijo.0802908.

Højlund K, Beck-Nielsen H. Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes? Curr Diabetes Rev. 2006;2:375-95. PMID: 18220643.

Frøsig C, Rose AJ, Treebak JT, Kiens B, Richter EA, Wojtaszewski JF. Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes. 2007;56:2093-102. PMID: 17513702. doi: 10.2337/db06-1698.

Wadley GD, Konstantopoulos N, Macaulay L, et al. Increased insulin-stimulated Akt pSer473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-term training. J Appl Physiol. 2007;102:1624-31. doi:10.1152/japplphysiol.00821.2006.

van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ. The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol (Lond.). 2001 Oct 1;536 (Pt 1):295-304. PMID: 11579177.

Otto Buczkowska E, Dworzecki T. The role of skeletal muscle in the regulation of glucose homeostasis. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2003;9(2):93-7. (in Polish). PMID: 14575619.